Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

US FDA Grants 510(k) Clearance For K2M’s tifix CAYMAN Plate Systems

K2M, Inc. announced that it has received 510(k) clearance from the US FDA to market its CAYMAN Buttress Plate System and CAYMAN Thoracolumbar Plate System. These devices have been designed to address the trauma and tumor market in the thoracolumbar, lumbar, and sacral areas of the spine. The CAYMAN product family is comprised of multiple implant systems, including a buttress plate to address graft expulsion, a lower lumbar sacral plate, and additional plating designs to secure and stabilize the anterior column. The low-profile plate features K2M’s proprietary tifix Locking Technology, a plate-screw locking technology whereby each screw head forms an autogenic lock to the plate upon insertion, requiring no additional locking mechanism. Additionally, the multi-directional screws allow for up to 45 degrees of angulation and lagging of the plate implant to the bone interface. “FDA clearance for our CAYMAN Plate Systems is an important expansion of our product offering to surgeons for treating trauma and tumor spinal patients. This comprehensive product family provides surgeons with a very low profile option for treating the spine from an anterior and lateral approach,” stated Eric Major, K2M’s President and CEO. “CAYMAN is also a critical compliment to our ALEUTIAN PEEK-OPTIMA spacer product lines by offering surgeons the opportunity to utilize both systems at the same time when treating the most difficult pathologies.”